A total of 99 patients has been enrolled to study circulating microRNAs, as diagnostic biomarkers, in patients with chronic stable coronary artery disease (CAD) and with acute myocardial infarction (AMI). For each patient, we have collected 10 mL of whole blood. All the samples have been processed maintaining the same conditions and timing. The samples with hemolysis and clots have been excluded from the study.